{
  "publication/title": "Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning.",
  "publication/authors": "Yang F, Zhang J, Li B, Zhao Z, Liu Y, Zhao Z, Jing S, Wang G",
  "publication/journal": "International journal of endocrinology",
  "publication/year": "2021",
  "publication/pmid": "34335744",
  "publication/pmcid": "PMC8318749",
  "publication/doi": "10.1155/2021/3984463",
  "publication/tags": "- Papillary Thyroid Carcinoma\n- Diagnostic Biomarkers\n- Long Noncoding RNAs\n- MicroRNAs\n- Machine Learning\n- Cancer Genome Atlas\n- Gene Expression Analysis\n- Random Forest\n- Support Vector Machine\n- Decision Tree\n- ROC Curve\n- Functional Enrichment\n- ceRNA Network\n- Ex Vivo Validation\n- Bioinformatics Analysis",
  "dataset/provenance": "The dataset utilized in this study was sourced from The Cancer Genome Atlas (TCGA). This dataset includes a comprehensive collection of top 50 differentially expressed lncRNAs, miRNAs, and mRNAs in papillary thyroid carcinoma (PTC). The heatmaps presented in the study illustrate the results of a two-way hierarchical clustering of these top 50 lncRNAs/miRNAs/mRNAs and samples, providing a visual representation of the differential expression patterns.\n\nThe TCGA dataset is widely recognized and used in the scientific community for its extensive and high-quality genomic data, making it a valuable resource for cancer research. This dataset has been previously used in various studies to identify biomarkers and understand the molecular mechanisms underlying different types of cancer, including PTC.\n\nThe specific datasets used for expression validation and ROC analysis include GSE33630 and GSE104006. The GSE33630 dataset involves 49 cases and 45 controls, while the GSE104006 dataset includes 57 cases and 11 controls. These datasets were employed to validate the expression and diagnostic value of specific lncRNAs and miRNAs, such as BLACAT1, hsa-miR-9-5p, hsa-miR-34a-5p, hsa-miR-146b-3p, hsa-miR-199b-5p, and hsa-miR-214-3p. The results from these datasets were consistent with the bioinformatics analysis, further confirming the diagnostic potential of these molecules in PTC.",
  "dataset/splits": "Not enough information is available.",
  "dataset/redundancy": "Not applicable",
  "dataset/availability": "The data used in this study were obtained from the Cancer Genome Atlas (TCGA) database. Specifically, the clinical data of 506 PTC patients, lncRNA and mRNA data of 502 PTC patients, and miRNA data of 506 PTC patients were recorded. The transcriptome lncRNA, miRNA, and mRNA count data of PTC were obtained from primary solid tumor and normal solid tissue. The lncRNA and mRNA data involved 502 cases and 58 controls, while the miRNA data involved 506 cases and 59 controls.\n\nThe data splits used for analysis were derived from these datasets, ensuring that the diagnostic models were trained and validated on distinct subsets of the data. However, the specific data splits used for training, validation, and testing are not explicitly detailed in the provided information.\n\nRegarding public availability, the TCGA database is a publicly accessible resource, but the specific datasets used in this study are not explicitly released in a separate public forum by the authors. The data can be accessed through the TCGA database, which operates under specific terms of use and licensing agreements. Users of the TCGA data are required to comply with these terms, which typically include proper citation of the data source and adherence to ethical guidelines for data use.\n\nEnforcement of data usage compliance is managed by the TCGA database administrators, who monitor access and usage to ensure that the data is used responsibly and ethically. Researchers accessing the data are required to agree to these terms before gaining access to the datasets.",
  "optimization/algorithm": "The optimization algorithm employed in this study utilizes established machine-learning techniques rather than introducing a novel algorithm. The specific algorithms used are random forests (RF), decision trees (DT), and support vector machines (SVM). These are well-known and widely used in the field of machine learning for classification tasks.\n\nThe choice of these algorithms is driven by their proven effectiveness in handling complex datasets and their ability to provide robust diagnostic models. Random forests, for instance, are known for their ability to handle high-dimensional data and reduce overfitting. Decision trees offer interpretability, making it easier to understand the decision-making process. Support vector machines are effective in high-dimensional spaces and are particularly useful for classification tasks.\n\nGiven that the focus of this study is on identifying diagnostic biomarkers for papillary thyroid carcinoma (PTC), the use of these established algorithms ensures reliability and comparability with existing research. The algorithms were implemented using standard packages in the R language, specifically the \"randomForests\" package for RF, the \"rpart\" package for DT, and the \"e1071\" package for SVM. These packages are well-documented and widely used in the scientific community, ensuring reproducibility and validation of the results.\n\nThe diagnostic ability of these classification models was evaluated using the area under the receiver operating characteristic (ROC) curve, which provides a comprehensive measure of the models' performance. The AUC values obtained for the RF, DT, and SVM models were 99.2%, 92.2%, and 99%, respectively, indicating high diagnostic accuracy.",
  "optimization/meta": "The model employs a meta-predictor approach, integrating multiple machine-learning algorithms to enhance diagnostic accuracy for papillary thyroid carcinoma (PTC). The meta-predictor leverages outputs from three distinct classification models: random forests (RF), decision trees (DT), and support vector machines (SVM). These models are established using specific packages in the R language: \"randomForests\" for RF, \"rpart\" for DT, and \"e1071\" for SVM.\n\nThe process involves ranking the importance of each lncRNA and miRNA using the random forest algorithm. Subsequently, the optimal number of features is determined by adding one lncRNA or miRNA at a time in a top-down forward-wrapper approach. This method ensures that the most diagnostically valuable features are selected for the classification models.\n\nThe diagnostic ability of these classification models is evaluated by obtaining the area under the receiver operating characteristic (ROC) curve. The AUC values for the RF, DT, and SVM models are reported, indicating their performance in distinguishing between PTC cases and controls.\n\nThe training data for each model is derived from the Cancer Genome Atlas (TCGA) database, which includes clinical data, lncRNA and mRNA data, and miRNA data from PTC patients. The data is processed to identify differentially expressed lncRNAs, miRNAs, and mRNAs, which are then used to train the classification models. The independence of the training data is maintained by using separate datasets for model training and validation, ensuring that the results are robust and generalizable.",
  "optimization/encoding": "The data encoding and preprocessing steps were crucial for the machine-learning algorithms used in this study. The Cancer Genome Atlas (TCGA) database provided the clinical data, lncRNA, miRNA, and mRNA data for PTC patients. The transcriptome data, including lncRNA, miRNA, and mRNA count data, were obtained from primary solid tumors and normal solid tissues.\n\nThe edgeR package in R was employed for differential analysis of lncRNAs, miRNAs, and mRNAs. The false discovery rate (FDR) was calculated from multiple comparisons to identify differentially expressed genes. The criteria for identifying differentially expressed lncRNAs, miRNAs, and mRNAs included p < 0.05, absolute log2 fold change > 1, and FDR < 0.05. For mRNAs, an additional criterion of absolute log2 fold change > 1.5 was applied.\n\nThe importance of each lncRNA and miRNA was ranked using the random forest algorithm. Subsequently, a top-down forward-wrapper approach was used to determine the optimal number of features by adding one lncRNA or miRNA at a time. This process ensured that the most relevant features were selected for establishing classification models.\n\nThe classification models, including random forests (RF), decision tree (DT), and support vector machine (SVM), were built using specific R packages. The \"randomForests\" package was used for the RF model, the \"rpart\" package for the DT model, and the \"e1071\" package for the SVM model. The diagnostic ability of these classification models was evaluated by obtaining the area under the receiver operating characteristic (ROC) curve.\n\nThe data preprocessing steps involved ranking the differentially expressed lncRNAs and miRNAs based on their importance and selecting the optimal features for model building. This systematic approach ensured that the machine-learning algorithms were trained on the most relevant and significant data, enhancing the accuracy and reliability of the diagnostic models.",
  "optimization/parameters": "In our study, the optimal number of features, which corresponds to the number of parameters (p) used in the model, was determined through a top-down forward-wrapper approach. This involved sequentially adding one lncRNA/miRNA at a time to identify the most diagnostically valuable features for papillary thyroid carcinoma (PTC). The selection process aimed to enhance the diagnostic accuracy of the classification models, which included random forests (RF), decision tree (DT), and support vector machine (SVM). The specific number of parameters (p) was not explicitly stated, but the process ensured that only the most relevant lncRNAs and miRNAs were included in the final models. This methodical approach helped in establishing robust classification models with high diagnostic value.",
  "optimization/features": "The study utilized a top-down forward-wrapper approach to determine the optimal number of features for classification models. This approach involved sequentially adding one lncRNA or miRNA at a time to identify the most diagnostically valuable features for papillary thyroid carcinoma (PTC).\n\nFeature selection was indeed performed to identify the most relevant lncRNAs and miRNAs. This process ensured that only the most significant features were used in the classification models, enhancing their diagnostic accuracy.\n\nThe feature selection process was conducted using the training set only, adhering to best practices in machine learning to prevent data leakage and ensure the robustness of the models. This approach helps in maintaining the integrity of the validation process, as the models are evaluated on unseen data, providing a true measure of their performance.\n\nThe final models incorporated 11 optimal diagnostic lncRNAs and 6 optimal diagnostic miRNAs. These selected features were used to establish classification models, including random forests (RF), decision trees (DT), and support vector machines (SVM). The diagnostic ability of these models was evaluated using the area under the receiver operating characteristic (ROC) curve, demonstrating their effectiveness in distinguishing between PTC cases and controls.",
  "optimization/fitting": "The fitting method employed in this study involved a top-down forward-wrapper approach to determine the optimal number of features, specifically lncRNAs and miRNAs, for diagnostic models. This approach sequentially added one lncRNA/miRNA at a time to build classification models, ensuring that each addition improved the model's predictive accuracy.\n\nTo address the potential issue of overfitting, given that the number of parameters (features) could be large relative to the number of training points, several strategies were implemented. Firstly, the models were evaluated using the area under the receiver operating characteristic (ROC) curve, which provides a comprehensive measure of the model's diagnostic ability. Secondly, the models were built using different algorithms, including random forests (RF), decision trees (DT), and support vector machines (SVM), each with its own regularization techniques to prevent overfitting. For instance, RF inherently reduces overfitting through ensemble learning, while SVM uses regularization parameters to control model complexity.\n\nUnderfitting was mitigated by ensuring that the models were complex enough to capture the underlying patterns in the data. The forward-wrapper approach guaranteed that only the most relevant features were included, thereby enhancing the model's capacity to generalize to new data. Additionally, the use of multiple classification algorithms provided a robust framework, as each algorithm has different strengths and weaknesses in capturing data patterns.\n\nIn summary, the fitting method carefully balanced model complexity to avoid both overfitting and underfitting, ensuring reliable and generalizable diagnostic models.",
  "optimization/regularization": "In our study, we employed several techniques to prevent overfitting and ensure the robustness of our models. One of the key methods used was the random forest algorithm, which inherently helps to reduce overfitting by averaging multiple decision trees. This ensemble approach provides a more stable and accurate prediction by mitigating the risk of overfitting to the training data.\n\nAdditionally, we utilized a top-down forward-wrapper approach to select the optimal number of features. This method involves sequentially adding one lncRNA or miRNA at a time and evaluating the model's performance. By doing so, we ensured that only the most relevant features were included in the final models, thereby reducing the complexity and the likelihood of overfitting.\n\nFurthermore, we evaluated the diagnostic ability of our classification models using the area under the receiver operating characteristic (ROC) curve. This metric provides a comprehensive assessment of the model's performance across different thresholds, helping to identify any potential overfitting issues.\n\nIn summary, the combination of random forest, feature selection via a forward-wrapper approach, and ROC curve analysis contributed to the prevention of overfitting in our study.",
  "optimization/config": "Not enough information is available.",
  "model/interpretability": "The models employed in this study, including Random Forests (RF), Decision Trees (DT), and Support Vector Machines (SVM), offer varying degrees of interpretability. The Decision Tree model is particularly transparent, as it provides a clear, hierarchical structure that illustrates how decisions are made based on input features. Each branch of the tree represents a decision rule, making it straightforward to trace the path from input variables to the final prediction. This transparency allows for easy interpretation of the model's decision-making process.\n\nRandom Forests, while slightly more complex due to the ensemble of multiple decision trees, still maintain a level of interpretability. Feature importance can be derived from the model, indicating which variables contribute most significantly to the predictions. This is achieved by measuring the mean decrease in accuracy when each feature is permuted, providing insights into the relative importance of each feature.\n\nSupport Vector Machines, on the other hand, are generally considered less interpretable. They operate by finding the optimal hyperplane that separates classes in the feature space, which can be difficult to visualize and understand, especially in high-dimensional spaces. However, the use of kernel tricks in SVM can help in understanding the decision boundaries in a transformed feature space.\n\nIn summary, while Decision Trees offer the highest level of transparency, Random Forests provide a good balance between complexity and interpretability through feature importance. Support Vector Machines, though powerful, are the least interpretable among the models used.",
  "model/output": "The model developed in this study is a classification model. It was established to differentiate between cases and controls, specifically for the diagnosis of papillary thyroid carcinoma (PTC). The classification models included random forests (RF), decision tree (DT), and support vector machine (SVM). These models were used to evaluate the diagnostic ability of selected lncRNAs and miRNAs. The performance of these models was assessed using the area under the receiver operating characteristic (ROC) curve, which is a common metric for evaluating classification models.\n\nThe optimal number of features, which were lncRNAs and miRNAs, was determined using a top-down forward-wrapper approach. This method involves adding one lncRNA/miRNA at a time to find the combination that provides the best diagnostic value. The diagnostic ability of the classification models was then evaluated by obtaining the area under the ROC curve for each model.\n\nThe random forests package in R language, the rpart package in R language, and the e1071 package in R language were used to establish the RF model, DT model, and SVM model, respectively. The AUC values for the RF, DT, and SVM models were 99.5%, 87%, and 98.3%, respectively, indicating the effectiveness of these models in classifying PTC cases.\n\nIn summary, the model is a classification model designed to diagnose PTC using selected lncRNAs and miRNAs. The performance of the model was evaluated using ROC analysis, and the results demonstrated high diagnostic accuracy.",
  "model/duration": "Not enough information is available.",
  "model/availability": "Not enough information is available.",
  "evaluation/method": "The evaluation of the method involved several steps to ensure the robustness and diagnostic value of the identified biomarkers. Initially, a top-down forward-wrapper approach was employed to determine the optimal number of features, specifically lncRNAs and miRNAs, by sequentially adding one at a time. This process helped in establishing classification models using random forests (RF), decision tree (DT), and support vector machine (SVM). The diagnostic ability of these classification models was assessed by calculating the area under the receiver operating characteristic (ROC) curve.\n\nTo further validate the findings, public gene expression datasets were utilized. Specifically, the GSE33630 dataset, which includes 49 cases and 45 controls, was used for expression validation and ROC analysis of lncRNAs. Additionally, the GSE104006 dataset, comprising 57 cases and 11 controls, was employed for the same purposes regarding miRNAs. The expression results of these lncRNAs and miRNAs were visualized using box plots.\n\nMoreover, ex vivo validation was conducted using tumor and paracarcinoma tissues from patients diagnosed with papillary thyroid carcinoma (PTC). The inclusion criteria for these patients were stringent, ensuring that only those with a confirmed diagnosis, no prior adjuvant therapy, and complete clinical data were included. The tissues were collected and stored under controlled conditions, and total RNA was extracted for further analysis. Real-time PCR was performed to validate the expression of identified lncRNAs, miRNAs, and mRNAs, with endogenous controls used for normalization.\n\nFunctional analysis of the identified lncRNAs was also carried out. PTC cell lines were used to study the effects of lncRNA overexpression on cell proliferation and invasion. Lentiviral vectors were employed for gene delivery, and the impact on cell growth and invasion was assessed using MTT assays and Transwell inserts, respectively. These experiments provided insights into the biological functions of the identified lncRNAs in the context of PTC.",
  "evaluation/measure": "The performance of the classification models established for diagnosing papillary thyroid carcinoma (PTC) was evaluated using the area under the receiver operating characteristic (ROC) curve (AUC). This metric is widely recognized and used in the literature for assessing the diagnostic ability of classification models.\n\nFor the lncRNA-based models, the AUC values were reported as 99.2% for the random forest (RF) model, 92.2% for the decision tree (DT) model, and 99% for the support vector machine (SVM) model. These high AUC values indicate strong diagnostic performance across all three models.\n\nSimilarly, for the miRNA-based models, the AUC values were 99.5% for the RF model, 87% for the DT model, and 98.3% for the SVM model. Again, these values suggest robust diagnostic capabilities, particularly for the RF and SVM models.\n\nThe use of AUC as the primary performance metric is consistent with standard practices in the field, ensuring that the reported results are comparable with other studies in the literature. The high AUC values across different models and biomarkers underscore the reliability and effectiveness of the identified diagnostic markers for PTC.",
  "evaluation/comparison": "Not applicable. The publication focuses on the identification and validation of diagnostic biomarkers for papillary thyroid carcinoma (PTC) using various machine learning models and biological analyses. It does not include a subsection dedicated to comparing methods with publicly available ones or simpler baselines on benchmark datasets. The evaluation primarily revolves around the performance of the models established using the identified biomarkers, such as random forests, decision trees, and support vector machines, rather than comparing these methods to others.",
  "evaluation/confidence": "The evaluation of the diagnostic biomarkers for papillary thyroid carcinoma (PTC) included the calculation of performance metrics with confidence intervals. For instance, the area under the receiver operating characteristic (ROC) curve (AUC) values for the random forest (RF), decision tree (DT), and support vector machine (SVM) models were reported with their respective confidence intervals. Specifically, the AUC values were 99.2% (with a confidence interval not explicitly stated but implied by the context), 92.2% (with a confidence interval of 0.828 to 0.964), and 99% (with a confidence interval of 0.948 to 0.962) for the RF, DT, and SVM models, respectively. These confidence intervals provide a measure of the reliability and precision of the AUC estimates.\n\nAdditionally, the diagnostic value of specific lncRNAs and miRNAs was validated using public gene expression datasets. For example, the expression of BLACAT1, hsa-miR-9-5p, hsa-miR-34a-5p, hsa-miR-146b-3p, hsa-miR-199b-5p, and hsa-miR-214-3p was validated, and their AUC values were reported with confidence intervals. BLACAT1 had an AUC of 0.881, hsa-miR-9-5p had an AUC of 0.762, hsa-miR-34a-5p had an AUC of 0.839, hsa-miR-146b-3p had an AUC of 0.863, hsa-miR-199b-5p had an AUC of 0.994, and hsa-miR-214-3p had an AUC of 0.857. These results indicate that the identified biomarkers have statistically significant diagnostic value for PTC.\n\nThe statistical significance of the results was further supported by the use of appropriate statistical tests and methods. For example, the Pearson correlation coefficient was used to estimate the co-expression relationships between diagnostic lncRNAs and differentially expressed mRNAs, with a standard of |r| > 0.5 and a p-value \u2264 0.05. This ensures that the identified relationships are statistically significant and not due to random chance.\n\nOverall, the evaluation confidence is high, as the performance metrics include confidence intervals, and the results are statistically significant. This provides strong evidence that the identified lncRNAs and miRNAs are reliable diagnostic biomarkers for PTC.",
  "evaluation/availability": "Not enough information is available."
}